Featured a Company on Bold Stocks

Archive for March, 2010

Medizone International, Inc. (OTCBB: MZEI) Hospitals Everywhere Scrambling for Solution

Monday, March 29th, 2010

Medizone International, Inc. (OTCBB: MZEI) (http://medizoneint.com)

There are so many reasons to be excited about the AsepticSure™ hospital sterilization system — and here is another one.  No matter how hard a cleaning crew tries to clean a hospital room MRSA may linger behind.  Hospitals MUST get a handle on infections.  Medicare no longer pays for Hospital Acquired Infection treatment.   Private Insurance is following suit.  State Legislatures are jumping on board.  The recent Duke University study which put the cost to treat an MRSA infection at $60,000 per patient put this problem in perspective.

Here is yet another study which supports the use the AsepticSure™ hospital sterilization system.  A Proctor and Gamble and Clorox found MRSA in spots that normal cleaning NEVER addresses such as the bottom of desk drawers.

The Proctor and Gamble and Clorox sponsored study tested surfaces and objects in 113 offices in five cities and found the superbug MRSA, isolated in 6% of offices.  It was found more often in men’s offices on the phone, computer mouse, desktop and the bottom of desk drawers although women’s offices had more than twice the bacteria of their male counterparts.

AsepticSure™ hospital sterilization system would be able to address those locations a cleaning crew might never find.

Contact

Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Vicor Technologies, Inc. (OTCBB: VCRT) Outstanding Rollout – Shareholder Value Window of Opportunity

Monday, March 29th, 2010

Vicor Technologies, Inc. (OTCBB: VCRT)

In January Vicor announced an exclusive distribution agreement for the PD2i Analyzer(TM) in South Carolina, North Carolina, and the cities of Savannah and Augusta, Georgia, and sold its first PD2i Analyzer(TM) to a U.S. physician.  The first PD2i Analyzer(TM) was purchased by a private, seven-provider family practice in Dillon, South Carolina, in addition to their in-house CAT scan, nuclear cardiology lab, x-ray, and endoscopy services.

This sale represents the very real probability that not ONLY hospitals will be interested in the PD2i Analyzer(TM) but private practice physicians have a real need and view this as a commercially viable product.  This expands the scope of sales tremendously and supports the underlying reality that the PD2i Analyzer(TM) is recognized as a viable service for patients whether in acute treatment settings or in a private medical practice.

Initial sales for a bio-tech company represent a tremendous window in time for shareholders to access the potential for incredible value.

Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and autonomic nervous system dysfunction, and trauma victims in need of lifesaving intervention.

Vicor Technologies, Inc.
2300 NW Corporate Blvd.
Suite 123
Boca Raton, FL 33431
877.528-PD2i (7324)
[email protected]

Disclaimer and Forward-Looking Statements
The appearance of name-brand institutions or products in this profile does not constitute endorsement by the U.S. Army Institute of Surgical Research, the U.S. Army Medical Research and Materiel Command, the Department of the Army, Department of Defense or the U.S. Government of the information, products or services contained therein.

Forward-looking statements in this profile are based on current plans and expectations that are subject to uncertainties and risks, which could cause the Company’s future results to differ materially. The following factors, among others, could cause the Company’s actual results to differ: the Company’s ability to obtain FDA approval of the PD2i VS™ (Vital Sign) for military and civilian applications and the PD2i CA™ (Cardiac Analyzer), the Company’s ability to continue to receive financing sufficient to continue operations and complete the critical clinical trials; the Company’s ability to continue as a going concern; the Company’s ability to successfully develop products based on the Company’s technologies, included but not limited to the Company’s ASP distribution model for the PD2i Analyzer™; the Company’s ability to obtain and maintain adequate levels of third-party reimbursement for the Company’s products; the impact of competitive products and pricing; the Company’s ability to receive regulatory approval for the Company’s products; the ability of third-party contract research organizations to perform preclinical testing and clinical trials for the Company’s technologies; the ability of third-party manufacturers to manufacture the Company’s products; the Company’s ability to retain the services of the Company’s key personnel; the Company’s ability to market and sell the Company’s products successfully; the Company’s ability to protect the Company’s intellectual property; product liability; changes in federal income tax laws and regulations; general market conditions in the medical device and pharmaceutical industries; and other matters that are described in Vicor’s Annual Report on Form 10-K for the fiscal year ended December 31, 2008 and subsequent filings with the Securities and Exchange Commission. Forward-looking statements in this press release speak only as of the date of the press release, and Vicor assume no obligation to update forward-looking statements or the reasons why actual results could differ.

Pentony Enterprises LLC is STOCKGURU.COM. 10604 Robincreek Lane; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated fifty thousand restricted common shares and seventy-two hundred dollars by the company for profile coverage for the period ending March 31, 2010. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. We will not be buying or selling shares of Vicor during the promotional period.

Medizone International, Inc. (OTCBB: MZEI) AsepticSure™ Eradicates C. Difficile Bacterium

Monday, March 29th, 2010

Medizone International, Inc. (OTCBB: MZEI) (http://medizoneint.com)

MRSA is the Hospital Acquired Infection gaining a tremendous amount of press at this time.  However there is a second infection lurking:  Clostridium difficile or C. difficile.

The AsepticSure™ hospital sterilization system is capable of decontamination to the previously unobtainable 6 log standard on all hospital surfaces, hard or soft. This incredible kill rate included fabric in addition to porcelain, formica and stainless steel.C Difficile Costs $1.6B and Causes 9,000 Deaths Annually

In addition to the cost-saving potential for MRSA C. difficile has tremendous cost saving as well.  Each year, an estimated 215,000 cases of hospital-acquired C. difficile occur in the USA, along with 263,000 in nursing homes. The hospital-acquired infections cost $1.6 billion a year to treat and result in 9,000 deaths, says the Centers for Disease Control and Prevention.

AsepticSure works against Clostridium difficile a bacterium spread by contact which can cause intestinal infections and death. It mainly strikes those over 65.

C. Difficile 25% More Common than MRSA

C. difficile was 25% more common than MRSA in a study of 28 hospitals infectious at Duke University Medical Center in Durham, N.C..  MRSA “was the big bad pathogen in hospitals,” but C. diff has overtaken it said researchers from the study at The Fifth Decennial: International Conference on Healthcare-Associated Infections 2010″.

In Ohio, a study of a quarter of state hospitals showed that following strict hygiene guidelines caused the number of cases to fall from 7.7 per 10,000 patient days in the hospital to 6.7, says Julie Mangino, a professor of internal medicine at Ohio State University Medical Center in Columbus.

Other states are targeting C. diff prevention using federal stimulus money.

What is C. Difficile?

C. difficile bacteria can be found throughout the environment — in soil, air, water, and human and animal feces. A small number of healthy people naturally carry the bacteria in their large intestine. But C. difficile is most common in hospitals and other health care facilities, where a much higher percentage of people carry the bacteria.

C. difficile bacteria are passed in feces and spread to food, surfaces and objects when people who are infected don’t wash their hands thoroughly. The bacteria produce hardy spores that can persist in a room for weeks or months. If you touch a surface contaminated with C. difficile, you may then unknowingly ingest the bacteria.

People in good health don’t usually get sick from C. difficile. Your intestines contain millions of bacteria, many of which help protect your body from infection. But when you take an antibiotic to treat an infection, the drug can destroy some of the normal, helpful bacteria as well as the bacteria causing the illness. Without enough healthy bacteria, C. difficile can quickly grow out of control. The antibiotics that most often lead to C. difficile infections include fluoroquinolones, cephalosporins, clindamycin and penicillins.

Once established, C. difficile can produce toxins that attack the lining of the intestine. The toxins destroy cells and produce patches (plaques) of inflammatory cells and decaying cellular debris inside the colon.

An aggressive strain of C. difficile has emerged that produces far more deadly toxins than other strains do. The new strain is more resistant to certain medications and has shown up in people who haven’t been in the hospital or taken antibiotics. This strain of C. difficile has caused several outbreaks of illness since 2000.

AsepticSure™ hospital sterilization system is effective against C. Difficile.

Contact

Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Medizone International, Inc. (OTCBB: MZEI)

Monday, March 29th, 2010

Medizone International, Inc. (OTCBB: MZEI) (http://medizoneint.com)

Hospital Acquired Infections are subject to scrutiny internationally and the cause is gaining steam weekly.

Duke University Hospital Acquired Infection Study

In the last month we received the results of a major study that tracked two diseases associated with MRSA receive tremendous media attention.  The Duke University Medical Center Study concluded that given the estimated cost of one MRSA case, a $60,000 intervention to prevent even one of these infections would be cost-effective for an institution.

In conjunction with medicare cost savings the Congress has examined hospital-acquired infections which are estimated in total by the Center for Disease Control to result in an estimated 1.7 million infections and as many as 99,000 deaths yearly. The cost is pegged at $45 billion annually. This short video explains the study You Tube Video .

United States Health Care Bill

As a result of the Health Care Bill The United States Central Budget Office credits Medicare payment reforms that seek to limit hospital readmissions and hospital-acquired infections with $7.1 billion in savings, and incentives that encourage physicians to group together in cost-saving organizations with $4.9 billion in savings.

International Conference on Healthcare-Associated Infections

For the first time ever four organizations came together last week in Atlanta to work together to eliminate hospital acquired infections:

  1. Society for Healthcare Epidemiology of America (SHEA)
  2. Centers for Disease Control and Prevention (CDC)
  3. Association for Professionals in Infection Control and Epidemiology (APIC)
  4. Infectious Diseases Society of America (IDSA)

The meeting entitled,  “The Fifth Decennial: International Conference on Healthcare-Associated Infections 2010″ represents the first time that the four leading scientific organizations collectively committed to infection prevention.  The four organizations are working together to further a scientific and educational agenda toward elimination of healthcare-associated infections (HAIs).

Canadian Hospital Acquired Infection Study

A the most comprehensive study on MRSA in Canada to be officially published in April noted MRSA rose 17 fold between 1995 and 2007.  It found a crucial need to manage Hospital Acquired Infections which confirms the dire need for the solution Medizone International brings to the table — and the fact that this is an international problem.   The authors said, “Why this is happening is not clear, but it is a worldwide pattern, occurring in the U.S., throughout Europe and Australia.”  This is an international problem and Medizone International intends to be a international company.

This is a dream scenario for MZEI.

Contact

Medizone International, Inc. (OTCBB: MZEI)
(See Medizone International Video)
http://www.medizoneint.com

Telephone: 415-868-0300
Fax: 415-868-2344
Address:
Post Office Box 742
Stinson Beach, CA 94970

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shars by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

Globotek Holdings Inc. is in the StockGuru Spotlight for March 29, 2010 

Monday, March 29th, 2010

DALLAS, TEXAS : StockGuru announces that Globotek Holdings Inc. (OTCBB: GBTO) is in the StockGuru Spotlight.   Globotek is the developer and owner of a unique technology for the processing of APG that is carried out at the drilling field by a Modular Mobile Structure. Globotek’s process involves the use of block-modular mobile complexes that each contain mini gas processing units and can be used in any environment where APG is flared. The advantages of the Globotek APG system are many but can be summarized as speed of construction and installation, small cost and a worldwide market. Russian legislation mandates that all oil fields in Russia must process APG to the international 95% standard by January 2012.

 

On Friday, the company put out news announcing that the licensing agreement to supply Energy Network Limited (ENL), a British Isles based energy investment enterprise has been executed and the Company further confirmed that once built, the project could add approximately USD$100 million in top line revenues to Globotek over the 10 year contractual period.

 

 

 

Shares for Globotek Holdings Inc. (OTCBB: GBTO) were steady during the day of trading on Friday and closed with no change at closing.

 

To view our StockGuru Spotlight on Globotek Holdings Inc. (OTCBB: GBTO), please visit:

http://www.stockguru.com 

 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the [email protected]  You may also telephone John Pentony at (469) 252-3031. 

 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: [email protected]

Dragon Pharmaceutical Inc. is in the StockGuru Spotlight for March 29, 2010

Monday, March 29th, 2010

 

DALLAS, TEXAS : StockGuru announces that Dragon Pharmaceutical Inc. (OTCBB: DRUG) is in the StockGuru Spotlight.   Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including Clavulanic Acid, an API to combine with Amoxicillin to fight resistance, and 7-ACA, a key intermediate to produce cephalosporin antibiotics, and formulated cephalosporin antibiotic drugs.

 

On Friday, the company put out news announcing that it has entered into a definitive merger agreement to be acquired by Chief Respect Limited, a Hong Kong corporation, which is a newly created entity controlled by Dragon Pharma’s Chairman and Chief Executive Officer, Yanlin Han, for $0.82 per share in cash. Mr. Han is the largest shareholder of the Company owning 37.95% of the total outstanding shares.

 

 

 

Shares for Dragon Pharmaceutical Inc. (OTCBB: DRUG) were up during the late afternoon of trading on Friday and closed up seven cents at closing.

 

To view our StockGuru Spotlight on Dragon Pharmaceutical Inc. (OTCBB: DRUG), please visit:

http://www.stockguru.com 

 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the [email protected]  You may also telephone John Pentony at (469) 252-3031. 

 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: [email protected]

Rotate Black Inc is in the StockGuru Spotlight for March 29, 2010

Monday, March 29th, 2010

 

DALLAS, TEXAS : StockGuru announces that Rotate Black Inc (OTCBB: ROBK) is in the StockGuru Spotlight.   Rotate Black is a U.S. based resort and gaming company that develops and manages resort and casino properties worldwide. The company is focused on acquiring distressed properties and management agreements and leveraging its gaming and turnaround experience to accelerate revenue growth and return the properties to long-term profitability. The company’s key executives have helped develop over 60 casinos and hotels/resorts.

 

On Friday, the company put out news announcing that the company has signed a letter of intent to lease and develop six acres at the former location of Marine Life Aquarium and Misco Marine in Gulfport, Miss.  The company plans to initially dock a 240 foot by 65 foot gaming vessel at the site. Formerly owned by Harrah’s Entertainment, the ship has 30,000 square feet of gaming space and two restaurants. The spacious ship with high ceilings recently underwent a $40 million renovation, including updating of the exterior, interior decor, mechanical and gaming systems.

 

 

 

Shares for Rotate Black Inc (OTCBB: ROBK) were up during the afternoon of trading on Friday and closed up two cents at closing.

 

To view our StockGuru Spotlight on Rotate Black Inc (OTCBB: ROBK), please visit:

http://www.stockguru.com 

 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the [email protected]  You may also telephone John Pentony at (469) 252-3031. 

 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: [email protected]

Harrington West Financial Group Inc. is in the StockGuru Spotlight for March 29, 2010

Monday, March 29th, 2010

 

DALLAS, TEXAS : StockGuru announces that Harrington West Financial Group Inc. (OTCBB: HWFG) is in the StockGuru Spotlight.   Harrington West Financial Group, Inc. is a $1.0 billion, diversified, financial institution holding company for Los Padres Bank, FSB. HWFG operates 14 full service banking offices on the central coast of California and the Phoenix Metro, Arizona. The Company also owns Harrington Wealth Management Company, a trust and investment management company with $159 million in assets under management or custody.

 

On Friday, the company put out news announcing that in connection with its voluntary delisting from NASDAQ and move to the Over the Counter Bulletin Board, it now qualifies to cease filing periodic and current reports under the Securities Act of 1934. Accordingly, on March 26, 2010, HWFG filed a Form 15 with the Securities and Exchange Commission certifying and providing notice of termination of registration under section 12(g) of the Securities Exchange Act of 1934, as amended, and a suspension of the duty to file reports under sections 13 and 15(d) of the Securities Exchange Act of 1934, as amended. With the filing of the Form 15, HWFG will not file an annual report on Form 10-K for the year ended December 31, 2009. HWFG expects to save approximately $250 thousand annually by not filing these reports. HWFG plans to release quarterly earnings reports on financial websites under its ticker and an annual report to shareholders. Los Padres Bank’s unaudited financial reports are available on the FDIC website at http://www2.fdic.gov/Call_TFR_Rpts/. HWFG plans to release its 2009 financial results on or about April 30, 2010 after the completion of its external audit and an Office of Thrift Supervision review. Quarterly earnings reports will be released approximately 60 days after quarter-end.

 

 

 

Shares for Harrington West Financial Group Inc. (OTCBB: HWFG) were down during the afternoon of trading on Friday and closed down five cents at closing.

 

To view our StockGuru Spotlight on Harrington West Financial Group Inc. (OTCBB: HWFG), please visit:

http://www.stockguru.com 

 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the [email protected]  You may also telephone John Pentony at (469) 252-3031. 

 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: [email protected]

Winland Online Shipping Holdings Corp. is in the StockGuru Spotlight for March 29, 2010

Monday, March 29th, 2010

 

 

DALLAS, TEXAS : StockGuru announces that Winland Online Shipping Holdings Corp. (OTCBB: WLOL) is in the StockGuru Spotlight.   Winland Online Shipping Holdings Corporation is a global shipping company with a fleet of 13 Company-owned vessels, mainly in the handysize and MPP (Multi-Purpose Vessel) category, engaged in international bulk cargo transportation. The Company also owns and operates “Shipping Online” — www.sol.com.cn — which is China’s largest shipping industry portal. Helping to transform the shipping industry in China, the site functions as not just an information provider, but as a business platform, providing on-line and off-line international shipping and logistics services, such as bulk cargo chartering, container booking, shipping agents, ship trading and building, spare parts supplies, crew recruitment as well as shipping news and data.

 

On Friday, the company put out news announcing that the Company’s revenues continued to be affected in 2009 by the global economic slowdown and the depressed global shipping market.  The Company reported revenues for the year ended December 31, 2009 decreased 40.4% to $50,178,721 compared with $84,206,001 in 2008. Net income in 2009 decreased to a loss of $(6,958,956) compared with net income of $19,071,337 in 2008.

 

 

 

Shares for Winland Online Shipping Holdings Corp. (OTCBB: WLOL) were steady during the late afternoon of trading on Friday and closed with no change at closing.

 

To view our StockGuru Spotlight on Winland Online Shipping Holdings Corp. (OTCBB: WLOL), please visit:

http://www.stockguru.com 

 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the [email protected]  You may also telephone John Pentony at (469) 252-3031. 

 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: [email protected]

Cortex Pharmaceuticals Inc. is in the StockGuru Spotlight for March 29, 2010

Monday, March 29th, 2010

 

DALLAS, TEXAS : StockGuru announces that Cortex Pharmaceuticals Inc. (OTCBB: CORX) is in the StockGuru Spotlight.   Cortex, located in Irvine, California, is a neuroscience company focused on novel drug therapies for treating psychiatric disorders, neurological diseases and sleep apnea. Cortex is pioneering a class of proprietary pharmaceuticals called AMPAKINE® compounds, which act to increase the strength of signals at connections between brain cells. The loss of these connections is thought to be responsible for memory and behavior problems in Alzheimer’s disease. Many psychiatric diseases, including schizophrenia, occur as a result of imbalances in the brain’s neurotransmitter system. These imbalances may be improved by using the AMPAKINE technology.

 

On Friday, the company put out news announcing it has entered into an agreement with Biovail Laboratories International SRL (“Biovail”) in which Biovail acquired certain AMPAKINE compounds and the rights to the patent filing for respiratory depression and vaso-occlusive crises associated with sickle cell disease. The transaction with Biovail includes a purchase price of $10,000,000 and additional payments of up to $15,000,000 based upon defined clinical development milestones.

 

 

 

Shares for Cortex Pharmaceuticals Inc. (OTCBB: CORX) were up during the afternoon of trading on Friday and closed slightly up at closing.

 

To view our StockGuru Spotlight on Cortex Pharmaceuticals Inc. (OTCBB: CORX), please visit:

http://www.stockguru.com 

 

What is the StockGuru Spotlight? 

The StockGuru Spotlight features stocks that we expect some action in. Generally speaking we expect a strong showing in the market based on the market, our knowledge of the stock and the buzz in the markets. Many times these will be stocks that have big news out recently, there is fresh interest in getting the word out on these stocks or we hear a buzz in our day to day contacts on these stocks. If we think it is going to move or see action, we put it in the StockGuru Spotlight.  If we are compensated for a stock in the Spotlight, it will be clearly disclosed within this Spotlight Announcement. 

 

If you think a company should be featued in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the [email protected]  You may also telephone John Pentony at (469) 252-3031. 

 

Stockguru.com (”SG”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 
 

John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: [email protected]

Copyright © 2008 - 2010 Pentony Capital LLC - All Rights Reserved.